9 months ago
33
Contagious respiratory disease can create more serious symptoms in people with low immunity
- Follow our Australia news live blog for latest updates
- Get our morning and afternoon news emails, free app or daily news podcast
A vaccine to combat a highly infectious respiratory disease has been approved for use in Australia.
The Therapeutic Goods Administration has ticked off Arexvy to be used as a respiratory syncytial virus vaccine for Australians aged 60 and over.
Continue reading...